Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone R Sackstein, JS Merzaban, DW Cain, NM Dagia, JA Spencer, CP Lin, ... Nature medicine 14 (2), 181-187, 2008 | 686 | 2008 |
Biocatalysis—key to sustainable industrial chemistry R Wohlgemuth Current opinion in biotechnology 21 (6), 713-724, 2010 | 410 | 2010 |
Orientation and flexibility of the choline head group in phosphatidylcholine bilayers J Seelig, HU Gally, R Wohlgemuth Biochimica et Biophysica Acta (BBA)-Biomembranes 467 (2), 109-119, 1977 | 247 | 1977 |
Towards large-scale synthetic applications of Baeyer-Villiger monooxygenases V Alphand, G Carrea, R Wohlgemuth, R Furstoss, JM Woodley TRENDS in Biotechnology 21 (7), 318-323, 2003 | 239 | 2003 |
Microscale technology and biocatalytic processes: opportunities and challenges for synthesis R Wohlgemuth, I Plazl, P Žnidaršič-Plazl, KV Gernaey, JM Woodley Trends in biotechnology 33 (5), 302-314, 2015 | 198 | 2015 |
High-yield biocatalytic amination reactions in organic synthesis J Ward, R Wohlgemuth Current organic chemistry 14 (17), 1914-1927, 2010 | 170 | 2010 |
Guidelines for reporting of biocatalytic reactions L Gardossi, PB Poulsen, A Ballesteros, K Hult, VK Švedas, Đ Vasić-Rački, ... Trends in biotechnology 28 (4), 171-180, 2010 | 167 | 2010 |
The use of enzymes in organic synthesis and the life sciences: perspectives from the Swiss Industrial Biocatalysis Consortium (SIBC) HP Meyer, E Eichhorn, S Hanlon, S Lütz, M Schürmann, R Wohlgemuth, ... Catalysis Science & Technology 3 (1), 29-40, 2013 | 156 | 2013 |
Encyclopedia of industrial biotechnology: bioprocess, bioseparation, and cell technology, 7 Volume Set MC Flickinger john wiley & sons, 2010 | 151 | 2010 |
Bioeconomy for sustainable development A Aguilar, T Twardowski, R Wohlgemuth Biotechnology Journal 14 (8), 1800638, 2019 | 147 | 2019 |
Biocatalysis for Green Chemistry and Chemical Process Development JA TAO, R KAZLAUSKAS | 138 | 2011 |
Asymmetric biocatalysis with microbial enzymes and cells R Wohlgemuth Current opinion in microbiology 13 (3), 283-292, 2010 | 133 | 2010 |
Reactor operation and scale‐up of whole cell Baeyer‐Villiger catalyzed lactone synthesis SD Doig, PJ Avenell, PA Bird, P Gallati, KS Lander, GJ Lye, ... Biotechnology progress 18 (5), 1039-1046, 2002 | 123 | 2002 |
Microbial transformations 59: First kilogram scale asymmetric microbial Baeyer‐Villiger oxidation with optimized productivity using a resin‐based in situ SFPR strategy I Hilker, R Wohlgemuth, V Alphand, R Furstoss Biotechnology and bioengineering 92 (6), 702-710, 2005 | 121 | 2005 |
Microbial Transformations, 56. Preparative Scale Asymmetric Baeyer–Villiger Oxidation using a Highly Productive “Two‐in‐One” Resin‐Based in situ SFPR Concept I Hilker, V Alphand, R Wohlgemuth, R Furstoss Advanced Synthesis & Catalysis 346 (2‐3), 203-214, 2004 | 121 | 2004 |
The headgroup conformation of phospholipids in membranes G Büldt, R Wohlgemuth The Journal of Membrane Biology 58, 81-100, 1981 | 110 | 1981 |
The locks and keys to industrial biotechnology R Wohlgemuth New Biotechnology 25 (4), 204-213, 2009 | 104 | 2009 |
Preparative scale Baeyer–Villiger biooxidation at high concentration using recombinant Escherichia coli and in situ substrate feeding and product removal process I Hilker, MC Gutiérrez, R Furstoss, J Ward, R Wohlgemuth, V Alphand Nature protocols 3 (3), 546-554, 2008 | 96 | 2008 |
Industrial biotechnology: sustainable growth and economic success W Soetaert, EJ Vandamme John Wiley & Sons, 2010 | 95 | 2010 |
The first 200-L scale asymmetric Baeyer− Villiger oxidation using a whole-cell biocatalyst CVF Baldwin, R Wohlgemuth, JM Woodley Organic Process Research & Development 12 (4), 660-665, 2008 | 94 | 2008 |